Skip to main content
Figure 2 | Journal of Inflammation

Figure 2

From: A comparison of adipose and bone marrow-derived mesenchymal stromal cell secreted factors in the treatment of systemic inflammation

Figure 2

BMSC-CM provides a greater survival benefit to LPS-treated mice than ASC-CM. 10 ug LPS were administered IP to each mouse to induce endotoxemia, followed by either 1 ml of saline (control), 1 ml BMSC-CM, or 1 ml ASC-CM IP. ASC-CM treated mice did not experience a significantly greater survival benefit in comparison to control (P = 0.924), whereas BMSC-CM treated mice did (P = 0.007).

Back to article page